Analysis of incidence of motor neuron disease in England 1998–2019: use of three linked datasets

References

• National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain), National Institute for Health and Care Excellence (Great Britain). Motor neurone disease: assessment and management. London: National Clinical Guideline Centre; 2016.
   Google Scholar
• McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. BMJ. 2008;336:658–62.
   PubMed Web of Science ®Google Scholar
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.
   PubMed Web of Science ®Google Scholar
• Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G, CARE-MND Consortium, et al. Changing epidemiology of motor neurone disease in Scotland. J Neurol. 2019;266:817–25.
   PubMed Web of Science ®Google Scholar
• Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2007;29:44–8.
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.
   PubMed Web of Science ®Google Scholar
• Nageshwaran S, Davies LM, Rafi I, Radunovi A. Motor neurone disease. BMJ. 2014;349:g4052–g4052.
   PubMed Web of Science ®Google Scholar
• Imam I, Ball S, Wright D, Hanemann CO, Zajicek J. The epidemiology of motor neurone disease in two counties in the southwest of England. J Neurol. 2010;257:977–81.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry. 1998;65:842–7.
   PubMed Web of Science ®Google Scholar
• Opie-Martin S, Ossher L, Bredin A, Kulka A, Pearce N, Talbot K, et al. Motor Neuron Disease Register for England, Wales and Northern Ireland—an analysis of incidence in England. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:86–8.
   PubMed Web of Science ®Google Scholar
• Gowland A, Opie-Martin S, Scott KM, Jones AR, Mehta PR, Batts CJ, et al. Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020–2116. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:264–74.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Stables D, Pringle M. QRESEARCH: a new general practice database for research. Inform Prim Care. 2004;12:49–50.
   PubMedGoogle Scholar
• Office for National Statistics. 2011 UK census data https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/2011censuspopulationestimatesfortheunitedkingdom/2012-12-17.
   Google Scholar
• US Population Data. US census. https://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf. 2010.
   Google Scholar
• Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor nueron disease in Scotland. J Neurol. 2007;254:866–9.
   PubMed Web of Science ®Google Scholar
• Kab S, Moisan F, Preux PM, Marin B, Elbaz A. Nationwide incidence of motor neuron disease using the French health insurance information system database. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:426–33.
   PubMed Web of Science ®Google Scholar
• Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for motor neurone disease in UK women: a prospective study. BMC Neurol. 2012;12:25.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol. 2000;57:109–13.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, for EURALS, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg & Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52:93–103.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. 2020 UK national life tables. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesunitedkingdomreferencetables.
   Google Scholar
• Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108–13.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Seals RM, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970–2009. Am J Epidemiol. 2013;178:1265–71.
   PubMed Web of Science ®Google Scholar
• Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi L-O, Sparén P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol. 2009;66:515–9.
   PubMed Web of Science ®Google Scholar
• Chiò A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Piemonte and Valle d’Aosta Register for ALS (PARALS), et al. Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d'Aosta Register. JAMA Neurol. 2017;74:1097–104.
   PubMed Web of Science ®Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Stevens DL. Appendix A: Neurology in the United Kingdom—numbers of clinical neurologists and trainees. J Neurol Neurosurg & Psychiatry. 1997;63:S67.
   Web of Science ®Google Scholar
• BBC News. Neurology care 'is lacking' for UK patients. https://wwwbbccouk/news/health-13665523. 2011.
   Google Scholar
• Nitkunan AL, Reilly MM. Association of British Neurologists UK Neurology Workforce Survey; ACNR 2020.
   Google Scholar
• Marin B, Fontana A, Arcuti S, Copetti M, Boumédiene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33:621–34.
   PubMed Web of Science ®Google Scholar
• de Jongh AD, van Eijk RPA, Peters SM, van Es MA, Horemans AMC, van der Kooi AJ, et al. Incidence, prevalence and geographical clustering of motor neuron disease in the Netherlands. Neurology. 2021;96:e1227–36.
   PubMed Web of Science ®Google Scholar
• Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, et al. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry. 2020;91:520–5.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, EURALS, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Henning F, Heckmann JM, Naidu K, Vlok L, Cross HM, Marin B. The incidence of motor neuron disease/amyotrophic lateral sclerosis in South Africa: a 4-year prospective study. Eur J Neurol. 2020;28:81–9.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Yeo L, Lynch C, Hardiman O. Validating population-based registers for ALS: how accurate is death certification? J Neurol. 2010;257:1235–9.
   PubMed Web of Science ®Google Scholar
• Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D'Alessandro R, et al. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Neuroepidemiology. 2004;23:73–7.
   PubMed Web of Science ®Google Scholar
• Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci. 1977;32:411–24.
   PubMed Web of Science ®Google Scholar
• Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ. 2013;346:f2350.
   PubMedGoogle Scholar
• Millett ERC, Quint JK, De Stavola BL, Smeeth L, Thomas SL. Improved incidence estimates from linked vs. stand-alone electronic health records. J Clin Epidemiol. 2016;75:66–9.
   PubMed Web of Science ®Google Scholar
• Horrocks S, Wilkinson T, Schnier C, Ly A, Woodfield R, Rannikmäe K, et al. Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: a systematic review. PLoS One. 2017;12:e0172639.
   PubMed Web of Science ®Google Scholar
• Kioumourtzoglou M-A, Seals RM, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:224–9.
   PubMed Web of Science ®Google Scholar